November 16th, 2026What Pharmacists Should Know About Shifting Peptide PolicyWith patients buying gray-market peptides, HHS’s draft policy aims to reunite prescribers, patients, and pharmacists around these emerging products.Read more
November 16th, 2026Gazyva Approved as First Drug for Primary Membranous NephropathyDespite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.Read more
November 16th, 2026FDA Expands Dexmedetomidine for At-Home UseFor patients with schizophrenia or bipolar I or II disorder, dexmedetomidine use will no longer require provider supervision.Read more
November 14th, 2026COVID-19 Vaccines Paid Off Up to $809 Per Dollar Spent in 2021High-income countries gained the most economic value from COVID-19 vaccines but low-income countries got the most per-person vaccinations relative to GDP.Read more
November 13th, 2026Vaxcyte’s VAX-31 Pneumococcal Vaccine Meets All Phase 3 Primary GoalsThe candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.Read more
November 13th, 2026New Report Finds Pharmacies Key in Long-Term GLP-1 SuccessThe Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.Read more
November 12th, 2026The Pharmacy Model Creating New Billing Pathways, Improved RecognitionThrough the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.Read more
November 12th, 2026Doxycycline Use Associated with Higher Risk of Pregnancy LossThe medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.Read more